Sentences with phrase «future outbreaks of the disease»

Scientists are now tracing climate variables to forecast future outbreaks of the disease (ClimateWire, Sept. 20, 2013).
The intent is to accelerate progress towards preventing and reducing future outbreaks of disease, detecting threats early and providing rapid, effective, coordinated responses to emerging threats.
My PhD career, funded with HELIX, will involve looking at how much society is willing to pay to confront future outbreaks of diseases like malaria.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
The outbreak of infectious diseases like SARS and bird flu in Asia in recent years has increased the urgency of Canadian governments at all levels to enhance their capacity to cope with possible future outbreaks in this country.
New York City Mayor Bill de Blasio has signed legislation aimed at preventing future outbreaks of Legionnaires» Disease.
Legislation passed in the wake of that outbreak requires building owners to register their cooling towers with the city, and City Council Speaker Melissa Mark - Viverito said members would now see if there are any additional steps they can take to help guard against future cases of Legionnaires» disease.
With the outbreak contained, Mr. de Blasio said attention was now turning on how to prevent future outbreaks of Legionnaires» disease with legislation that will require inspections and cleaning of cooling towers — an area where he and Mr. Cuomo had originally sparred but have now landed on the same page.
«This summer's outbreak of Legionnaires» disease caused concern in communities across the state, and today we are moving forward to help prevent future outbreaks and keep our neighborhoods safe,» Mr. Cuomo said in a statement.
LEGIONNAIRES» FALLOUT: Monday morning at City Hall, Mayor Bill de Blasio will hold a bill - signing ceremony, beginning at 10 a.m. (full details below), and then, around noon, «the Mayor, Speaker Melissa Mark - Viverito and elected officials will host a press conference to introduce new legislation to reduce future risk of Legionnaires» disease, and provide an update on the containment of the outbreak,» according to the mayor's public schedule.
Pandemic preparedness is not only critical because of the threat of a future pandemic or an outbreak of an emerging infectious disease, but also because school preparedness for all types of disasters, including biological events, is mandated by the U.S. Department of Education.
Using a vaccine to take a disease out of the mix could leave a population vulnerable to future outbreaks should the vaccine become ineffective or stop being used.
The way we prepare for, and respond to, future outbreaks of Ebola and other infectious diseases needs to be strengthened.»
Preventing a future crisis like Ebola requires better diagnostic tools and disease surveillance networks so that outbreaks can be identified and stopped before they get out of hand.
Safe and effective vaccines could help end the ongoing Ebola virus disease epidemic in parts of West Africa and stop future outbreaks of the virus.
In September 2015 the Science Media Centre submitted written evidence to the Commons Science and Technology Select Committee on what lessons have been drawn from the Ebola outbreak last year concerning the use of scientific advice in the UK for similar disease outbreak emergencies in future.
While this study focused on the foot - and - mouth outbreak, the method could also be used for planning purposes in the event of a future outbreak of other infectious diseases in livestock.
The complex viromes of different human as well as wild and domesticated animal populations are also characterized to allow future changes associated with disease outbreak to be rapidly identified.
An international effort to analyze the entire database of Ebola virus genomes from the 2013 — 2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real - time sequencing and data - sharing to contain future viral disease outbreaks.
The future of infectious disease surveillance and outbreak response is trending towards smaller hand - held solutions for point - of - need pathogen detection.
Future pandemic flu outbreaks would be ranked, like hurricanes, on a scale of 1 to 5, and school closures of up to three months would be recommended for more severe outbreaks, according to a planning guide released jointly last week by the Department of Education, the Department of Health and Human Services, and the U.S. Centers for Disease Control and Prevention.
Many diagnostic tests can be of tremendous value in helping shelters prevent future outbreaks of infectious disease.
The program teaches current and future veterinarians to treat and prevent disease; provides high quality care to sick, injured, and abused animals; consults on population health and protocols, including diagnostic assistance in instances of disease outbreaks; helps reduce pet overpopulation and euthanasia through spay / neuter programs; and improves animal health through education of new and existing pet owners.
There are multiple studies associating extreme precipitation events with waterborne disease outbreaks and strong climatological evidence for increasing frequency and intensity of extreme precipitation events in the future.
With climate change, we may start seeing outbreaks of diseases occurring in the near future.
My research entails measuring the benefits of avoiding such disease outbreaks in the future.
Outbreaks of native insects and diseases are expected to occur in response to future warming temperatures and a drier environment, but tree mortality is not likely to be uniformly distributed across the landscape.
Plant genetic diversity also has the potential to provide traits that can help meet future challenges, such as the need to adapt crops to changing climatic conditions or outbreaks of disease
They stress the importance of maintaining a diversity within each crop, because: «Plant genetic diversity also has the potential to provide traits that can help meet future challenges, such as the need to adapt crops to changing climatic conditions or outbreaks of disease
a b c d e f g h i j k l m n o p q r s t u v w x y z